- Home
- ATEX vs AGL Comparison
ATEX vs AGL Comparison
Compare ATEX & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATEX
- AGL
- Stock Information
- Founded
- ATEX 1997
- AGL 2016
- Country
- ATEX United States
- AGL United States
- Employees
- ATEX N/A
- AGL N/A
- Industry
- ATEX Telecommunications Equipment
- AGL Managed Health Care
- Sector
- ATEX Telecommunications
- AGL Health Care
- Exchange
- ATEX Nasdaq
- AGL Nasdaq
- Market Cap
- ATEX 381.9M
- AGL 443.4M
- IPO Year
- ATEX N/A
- AGL 2021
- Fundamental
- Price
- ATEX $19.57
- AGL $0.96
- Analyst Decision
- ATEX Buy
- AGL Hold
- Analyst Count
- ATEX 2
- AGL 20
- Target Price
- ATEX $58.50
- AGL $2.75
- AVG Volume (30 Days)
- ATEX 202.4K
- AGL 6.4M
- Earning Date
- ATEX 11-12-2025
- AGL 11-04-2025
- Dividend Yield
- ATEX N/A
- AGL N/A
- EPS Growth
- ATEX N/A
- AGL N/A
- EPS
- ATEX 1.58
- AGL N/A
- Revenue
- ATEX $5,924,000.00
- AGL $5,901,182,000.00
- Revenue This Year
- ATEX N/A
- AGL N/A
- Revenue Next Year
- ATEX $5.18
- AGL $5.76
- P/E Ratio
- ATEX $12.46
- AGL N/A
- Revenue Growth
- ATEX 15.97
- AGL 11.76
- 52 Week Low
- ATEX $19.26
- AGL $0.71
- 52 Week High
- ATEX $42.91
- AGL $6.08
- Technical
- Relative Strength Index (RSI)
- ATEX 35.65
- AGL 42.02
- Support Level
- ATEX $19.26
- AGL $0.93
- Resistance Level
- ATEX $20.98
- AGL $1.03
- Average True Range (ATR)
- ATEX 0.77
- AGL 0.09
- MACD
- ATEX -0.20
- AGL 0.01
- Stochastic Oscillator
- ATEX 11.25
- AGL 36.76
About ATEX Anterix Inc.
Anterix Inc is a United States-based company engaged in delivering broadband needed to modernize infrastructure for energy, transportation, logistics, and other industries. The company offers Private LTE for utilities which help to automate processes, monitor environmental conditions, enable artificial intelligence, and drive productivity.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.